Astrazeneca, Sanofi Team Up To Make Breathing-Illness Vaccine
March 03 2017 - 2:59AM
Dow Jones News
By Olga Cotaga
LONDON--AstraZeneca PLC (AZN.LN) and Sanofi SA (SNY) are teaming
up to work on a vaccine that prevents lower respiratory tract
illness in a new multimillion-euro joint venture.
The U.K. pharmaceutical company said on Friday that it would
develop and sell an antibody for a vaccine to innoculate patients
against the respiratory syncytial virus to its French counterpart's
vaccines division.
Sanofi would make an up-front payment of 120 million euros
($127.3 million) and then pay AstraZeneca up to EUR495 million
depending on whether certain production and sales targets are met,
the U.K. company said.
AstraZeneca is to handle the manufacturing of the vaccine while
Sanofi will sell the product, with the companies splitting the
costs and profits equally, AstraZeneca said.
-Write to Olga Cotaga at olga.cotaga@wsj.com, Twitter
@OlgaCotaga
(END) Dow Jones Newswires
March 03, 2017 02:44 ET (07:44 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024
